This contract opportunity is for the supply of parenteral medicines, divided into eight categories based on active ingredients, for a planned procurement period of 36 months. The medicines include paracetamol, hydrocortisone, octreotide, magnesium sulfate 10%, dexmedetomidine, creatine phosphate, ro
Contract awarded. Originally published 10 months ago.
This contract opportunity involves the procurement of a specialized medical device known as a transcatheter system with a self-expanding aortic valve. This device is intended for specific clinical indications and will be used by the Department of Interventional Cardiology. The procurement period is
This contract opportunity involves the procurement of parenteral medicines categorized into eight parts based on their active ingredients. The planned procurement period is 36 months and includes the following medicines: paracetamol, hydrocortisone, octreotide, magnesium sulfate 10%, dexmedetomidine
This contract involves the supply of medical, technical, and special gases, including the rental of storage tanks and related services, for a duration of 36 months. A detailed description of the contract's subject is included in the competition documents, section B.2.
This contract involves the procurement of specialized medical materials known as Short-Term Intracardiac Catheter Mechanical Heart Support. These devices are intended for use in the Operating Rooms of the Cardiac Surgery Department, the Interventional Cardiology Department, and the Cardiac Surgery a
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
